178 related articles for article (PubMed ID: 22493267)
1. Heritable polymorphism predisposes to high BAALC expression in acute myeloid leukemia.
Eisfeld AK; Marcucci G; Liyanarachchi S; Döhner K; Schwind S; Maharry K; Leffel B; Döhner H; Radmacher MD; Bloomfield CD; Tanner SM; de la Chapelle A
Proc Natl Acad Sci U S A; 2012 Apr; 109(17):6668-73. PubMed ID: 22493267
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of rs62527607 [GT] single nucleotide polymorphism located in BAALC gene in children with acute leukemia using mismatch PCR-RFLP.
Nadimi M; Rahgozar S; Moafi A; Tavassoli M; Mesrian Tanha H
Cancer Genet; 2016; 209(7-8):348-53. PubMed ID: 27372260
[TBL] [Abstract][Full Text] [Related]
3. RUNX1 variant as a genetic predisposition factor for acute myeloid leukemia.
Javadlar M; Dastar S; Gharesouran J; Ghafouri-Fard S; Hosseinzadeh H; Moradi M; Mazraeh SA; Nasiri Ganjineh Ketab F; Rezamand A; Hiradfar A; Taheri M; Rezazadeh M
Exp Mol Pathol; 2020 Aug; 115():104440. PubMed ID: 32294461
[TBL] [Abstract][Full Text] [Related]
4. Intronic miR-3151 within BAALC drives leukemogenesis by deregulating the TP53 pathway.
Eisfeld AK; Schwind S; Patel R; Huang X; Santhanam R; Walker CJ; Markowitz J; Hoag KW; Jarvinen TM; Leffel B; Perrotti D; Carson WE; Marcucci G; Bloomfield CD; de la Chapelle A
Sci Signal; 2014 Apr; 7(321):ra36. PubMed ID: 24736457
[TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of CEBPA mutations and BAALC expression in acute myeloid leukemia Egyptian patients with normal karyotype.
El-Sharnouby JA; Ahmed LM; Taha AM; Kamal O
Egypt J Immunol; 2008; 15(1):131-43. PubMed ID: 20306678
[TBL] [Abstract][Full Text] [Related]
6. BAALC overexpression retains its negative prognostic role across all cytogenetic risk groups in acute myeloid leukemia patients.
Damiani D; Tiribelli M; Franzoni A; Michelutti A; Fabbro D; Cavallin M; Toffoletti E; Simeone E; Fanin R; Damante G
Am J Hematol; 2013 Oct; 88(10):848-52. PubMed ID: 23760853
[TBL] [Abstract][Full Text] [Related]
7. BAALC and WT1 expressions from diagnosis to hematopoietic stem cell transplantation: consecutive monitoring in adult patients with core-binding-factor-positive AML.
Yoon JH; Kim HJ; Shin SH; Yahng SA; Lee SE; Cho BS; Eom KS; Kim YJ; Lee S; Min CK; Cho SG; Kim DW; Lee JW; Min WS; Park CW; Lim JH
Eur J Haematol; 2013 Aug; 91(2):112-21. PubMed ID: 23672350
[TBL] [Abstract][Full Text] [Related]
8. BAALC and ERG expression levels at diagnosis have no prognosis impact on acute myeloid leukemia patients undergoing allogeneic hematopoietic stem cell transplantation.
Zhang J; Shi J; Zhang G; Zhang X; Yang X; Yang S; Wang J; Ke X; Fu L
Ann Hematol; 2018 Aug; 97(8):1391-1397. PubMed ID: 29696374
[TBL] [Abstract][Full Text] [Related]
9. Prognostic significance of combined BAALC and MN1 gene expression level in acute myeloid leukemia with normal karyotype.
Marjanovic I; Karan-Djurasevic T; Kostic T; Virijevic M; Vukovic NS; Pavlovic S; Tosic N
Int J Lab Hematol; 2021 Jun; 43(3):433-440. PubMed ID: 33242229
[TBL] [Abstract][Full Text] [Related]
10. BAALC-associated gene expression profiles define IGFBP7 as a novel molecular marker in acute leukemia.
Heesch S; Schlee C; Neumann M; Stroux A; Kühnl A; Schwartz S; Haferlach T; Goekbuget N; Hoelzer D; Thiel E; Hofmann WK; Baldus CD
Leukemia; 2010 Aug; 24(8):1429-36. PubMed ID: 20535151
[TBL] [Abstract][Full Text] [Related]
11. Risk assessment in patients with acute myeloid leukemia and a normal karyotype.
Bienz M; Ludwig M; Leibundgut EO; Mueller BU; Ratschiller D; Solenthaler M; Fey MF; Pabst T
Clin Cancer Res; 2005 Feb; 11(4):1416-24. PubMed ID: 15746041
[TBL] [Abstract][Full Text] [Related]
12. BAALC and ERG expression levels are associated with outcome and distinct gene and microRNA expression profiles in older patients with de novo cytogenetically normal acute myeloid leukemia: a Cancer and Leukemia Group B study.
Schwind S; Marcucci G; Maharry K; Radmacher MD; Mrózek K; Holland KB; Margeson D; Becker H; Whitman SP; Wu YZ; Metzeler KH; Powell BL; Kolitz JE; Carter TH; Moore JO; Baer MR; Carroll AJ; Caligiuri MA; Larson RA; Bloomfield CD
Blood; 2010 Dec; 116(25):5660-9. PubMed ID: 20841507
[TBL] [Abstract][Full Text] [Related]
13. Over expression of brain and acute leukemia, cytoplasmic and ETS-related gene is associated with poor outcome in acute myeloid leukemia.
Hasan SK; Patkar NV; Rajamanickam D; Gokarn A; Lucena-Araujo AR; Tembhare P; Bagal B; Kadam Amare P; Jain H; Gujral S; Sengar M; Subramanian PG; Khattry N
Hematol Oncol; 2020 Dec; 38(5):808-816. PubMed ID: 32893896
[TBL] [Abstract][Full Text] [Related]
14. miR-3151 interplays with its host gene BAALC and independently affects outcome of patients with cytogenetically normal acute myeloid leukemia.
Eisfeld AK; Marcucci G; Maharry K; Schwind S; Radmacher MD; Nicolet D; Becker H; Mrózek K; Whitman SP; Metzeler KH; Mendler JH; Wu YZ; Liyanarachchi S; Patel R; Baer MR; Powell BL; Carter TH; Moore JO; Kolitz JE; Wetzler M; Caligiuri MA; Larson RA; Tanner SM; de la Chapelle A; Bloomfield CD
Blood; 2012 Jul; 120(2):249-58. PubMed ID: 22529287
[TBL] [Abstract][Full Text] [Related]
15. shRNA-Mediated BAALC knockdown affects proliferation and apoptosis in human acute myeloid leukemia cells.
Xu B; Chen G; Shi P; Guo X; Xiao P; Wang W; Zhou S
Hematology; 2012 Jan; 17(1):35-40. PubMed ID: 22549446
[TBL] [Abstract][Full Text] [Related]
16. iPSC modeling of stage-specific leukemogenesis reveals BAALC as a key oncogene in severe congenital neutropenia.
Dannenmann B; Klimiankou M; Oswald B; Solovyeva A; Mardan J; Nasri M; Ritter M; Zahabi A; Arreba-Tutusaus P; Mir P; Stein F; Kandabarau S; Lachmann N; Moritz T; Morishima T; Konantz M; Lengerke C; Ripperger T; Steinemann D; Erlacher M; Niemeyer CM; Zeidler C; Welte K; Skokowa J
Cell Stem Cell; 2021 May; 28(5):906-922.e6. PubMed ID: 33894142
[TBL] [Abstract][Full Text] [Related]
17. Simultaneous changes in expression levels of BAALC and miR-326: a novel prognostic biomarker for childhood ALL.
Ghodousi ES; Aberuyi N; Rahgozar S
Jpn J Clin Oncol; 2020 Jun; 50(6):671-678. PubMed ID: 32129446
[TBL] [Abstract][Full Text] [Related]
18. ERG expression is an independent prognostic factor and allows refined risk stratification in cytogenetically normal acute myeloid leukemia: a comprehensive analysis of ERG, MN1, and BAALC transcript levels using oligonucleotide microarrays.
Metzeler KH; Dufour A; Benthaus T; Hummel M; Sauerland MC; Heinecke A; Berdel WE; Büchner T; Wörmann B; Mansmann U; Braess J; Spiekermann K; Hiddemann W; Buske C; Bohlander SK
J Clin Oncol; 2009 Oct; 27(30):5031-8. PubMed ID: 19752345
[TBL] [Abstract][Full Text] [Related]
19. Histone post-translational modifications associated to BAALC expression in leukemic cells.
Franzoni A; Passon N; Fabbro D; Tiribelli M; Damiani D; Damante G
Biochem Biophys Res Commun; 2012 Jan; 417(2):721-5. PubMed ID: 22197554
[TBL] [Abstract][Full Text] [Related]
20. Identification and functional analysis of acute myeloid leukemia susceptibility associated single nucleotide polymorphisms at non-protein coding regions of RUNX1.
Xu X; Ren X; Wang H; Zhao Y; Yi Z; Wang K; Zhang S; Wang L; Samuelson DJ; Hu Z
Leuk Lymphoma; 2016; 57(6):1442-9. PubMed ID: 26374622
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
